Concepedia

Molly L. Udaskin

ML

Statistics

Publications

5

Citations

550

H-Index

5

Active since

2013

Affiliations

University Health Network(Current)

University of Toronto

Princess Margaret Cancer Centre

St. Michael's Hospital

Université de Montréal

Molly L. Udaskin is an author at University Health Network specializing in oncology, medicine, and molecular oncology.

Publications per year

2013–2023

5

Publications

5

Spatially confined sub-tumor microenvironments in pancreatic cancer

Barbara T. Grünwald, Antoine Devisme, Geoffroy Andrieux et al. · Cell · 2021 · 423 citations · Full text

, , +17

The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors

Teklab Gebregiworgis, Yoshihito Kano, Jonathan St‐Germain et al. · Nature Communications · 2021 · 46 citations · Full text

, , +17

Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer

Helen E. Burston, Oliver A. Kent, Laudine Communal et al. · Journal of Clinical Investigation · 2021 · 34 citations · Full text

, , +16

The D3 Bacteriophage α-Polymerase Inhibitor (Iap) Peptide Disrupts O-Antigen Biosynthesis through Mimicry of the Chain Length Regulator Wzz in Pseudomonas aeruginosa

Véronique L. Taylor, Molly L. Udaskin, Salim T. Islam et al. · Journal of Bacteriology · 2013 · 27 citations · Full text

, , +10

Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer

Skye Alexandre Sauriol, Eurı́dice Carmona, Molly L. Udaskin et al. · Scientific Reports · 2023 · 20 citations · Full text

, , +16

1–5 of 5